Stay updated on Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study locations list was updated to add multiple new sites across various countries/regions and to remove several existing sites. This changes the enrollment options and where data collection for the trial will occur.SummaryDifference2%

- Check48 days agoChange DetectedRevision: v3.3.2 was applied, replacing the previous v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedPublications section now notes that entries are automatically filled from PubMed and adds a Revision: v3.3.1; the prior PubMed-related wording has been replaced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded a new study site: Tainan, Taiwan. Removed the Tainan City, Taiwan listing and the government funding notice banner to reflect updated site information.SummaryDifference0.1%

- Check77 days agoChange DetectedNo significant changes to core study details are visible; only minor UI/layout adjustments appear across the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check106 days agoChange Detected- Updated revision from v3.0.2 to v3.2.0. This indicates a new version release, but does not alter core content or other important data.SummaryDifference0.0%

Stay in the know with updates to Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.